+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Life Sciences Industry Outlook, 2018

  • Report

  • 98 Pages
  • April 2018
  • Region: Global
  • Frost & Sullivan
  • ID: 4521792

Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments

The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from payers to providers have provided a strong impetus to the growth of the life sciences industry. The convergence of biopharmaceuticals, drug delivery devices, and companion diagnostics enabled by the digital connectivity is driving regulatory and commercial changes in many exciting ways for the industry. With the synergistic effect of advanced technologies, such as Artificial Intelligence, Big Data analytics, and cloud computing on the traditional life sciences industry, growth could be even faster in 2018. The paradox of the new growth rate is that its taking place even as the industry is grappling with the larger question - when will precision healthcare become a reality?

This research deliverable provides bold perspectives and predictions for the global life sciences industry in 2018. The markets covered include pharmaceuticals and biotechnology, in vitro diagnostics, and research tools. The analysis captures the sectoral and regional trends and predictions that are expected to transpire over the upcoming year as organizations shift to prepare for the future. The key objective of this research service is to enable clients to identify growth opportunities and devise potential growth strategies in the transformational life sciences ecosystem. The report also provides a futuristic perspective on the competitive landscape, market, and technology trends. Life sciences experts envisage:

  • Payers rapidly moving toward outcome-based assessment models and trials. Drug companies will witness a shift from quantity-based, fee-for-service model to value and outcome-based contracts.
  • Preventive healthcare driven by predictive analytics to determine the likelihood of disease progression. Several oncology focused-startup companies will take the lead in Big Data.
  • Lab test payments significantly cut by PAMA regulations. Revision of the EU-IVDR triggers delays in the new product launch. Reimbursement for digital therapeutics will become critical.
  • X-as-a-Service Model (XaaS) will open new revenue streams and impact top line revenues of genomic services providers.
  • Small and mid-sized companies attracting Big Pharma. Favorable tax reforms and competition for new assets could, in turn, lead to higher valuations and product deal amounts.

Key Issues Addressed

  • What are the main factors that will influence the size and direction of the global life sciences industry in 2018?
  • How does the industry outlook vary from region to region?
  • What is the outlook for pharmaceutical & biotechnology and IVD & research tools in each region during 2018?
  • What technology developments in the global life sciences industry in 2017 will have an impact during 2018?
  • What will be the key growth opportunities and strategic imperatives for companies in 2018?

Table of Contents

1. Executive Summary
  • Key Findings
  • Top Predictions for 2018-Global Life Sciences Industry
  • Top Trends for 2018-Global Life Sciences Industry
  • The 2017 Global Life Sciences Industry-Actuals Versus Forecast
  • Global Life Sciences Industry Sales Forecast-2018
  • Global Life Sciences Industry Sales by Region in 2017 and 2018
  • 2018 Global Perspective-Developed Markets
  • 2018 Global Perspective-Emerging Markets

2. Research Scope, Objectives, Methodology, and Background
  • Research Scope and Segmentation
  • Market Segmentation-Pharma & Biotech
  • Market Segmentation-IVD & Research Tools
  • Research Aims and Objectives
  • Key Questions this Study will Answer

3. 2018 Pharmaceutical & Biotechnology Outlook
  • Global Pharma & Biotech Market Revenue Forecast
  • Global Pharmaceutical Sales in 2016 and 2017-A Snapshot
  • Key 2018 Pharmaceutical & Biotechnology Market Trends
  • Prediction 1-Drug Discovery and Clinical Development IT Solutions Spend to Exceed $10 B in 2018
  • Prediction 2-Outsourcing of Bio-analytical and cGMP Services will Breach the ~$8.5 Billion Mark in 2018
  • Prediction 3-Small and Mid-sized Companies Attracting Big Pharma
  • 2018 Regional Outlook-Pharma & Biotech Market
  • Key Regional Market-US
  • Key Regional Market-Europe
  • Key European Markets
  • Key Regional Market-Japan
  • Key Regional Market-China
  • Key Regional Market-India
  • Key APAC Markets
  • Key Regional Pharma Market-Latin America
  • Key Regional Pharma Market-Brazil
  • Key Regional Market-Africa
  • Disruptive Market Participants

4. 2018 IVD & Research Tools Outlook
  • Global IVD Market Revenue Forecast
  • Global Research Tools Market Forecast
  • Global IVD Sales in 2016 and 2017-A Snapshot
  • Key 2018 IVD & Research Tools Market Trends
  • Prediction 2-Disruptive Start-ups Take Lead in Oncology and Big Data
  • Prediction 3-Reimbursement and Regulatory Headwinds Impact IVD Companies in Major Geographies
  • Prediction 4-Research labs jump-start spending on Cloud, NGS & Big Data analytics solutions
  • 2018 Regional Outlook-IVD Market
  • Key Regional Market-US
  • Key Regional Market-Europe
  • Key European Markets
  • Key Regional Market-Japan
  • Key Regional Market-China
  • Key Regional Market-India
  • Key APAC Markets
  • Key Regional Market-Latin America
  • Key Regional Market-Brazil
  • Key Regional Market-Africa
  • Disruptive Start-Ups Aiming for Next-generation Diagnostics

5. Global Life Sciences Industry Technology Outlook
  • New Product/Technology/Service Approval/Launches 2017
  • Key Converging Technologies for Pharma & Biotech Industry Driving Data Integrity and Continuity Across the Value Chain
  • Key Converging Technologies for Diagnostics & Research Tools Industry Driving Healthcare Consumerization

6. Growth Opportunities and Companies to Action
  • 5 Major Growth Opportunities
  • Growth Opportunity 1-Immuno-oncology
  • Growth Opportunity 2-Cell Banking
  • Growth Opportunity 3-Single-use Manufacturing
  • Growth Opportunity 4-Point of Care Testing
  • Growth Opportunity 5-Genomics
  • Strategic Imperatives for Life Sciences Companies

7. Key Conclusions and Future Outlook
  • Key Conclusions and Future Outlook
  • Legal Disclaimer

8. Appendix
  • List of Exhibits
  • Abbreviations and Terms Used
  • Pharma 2.0 2018 Titles
  • Next Generation Diagnostics & Research Tools 2018 Titles
  • Additional Sources of Information